Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-41,449
Closed -$2.74M 739
2018
Q1
$2.74M Sell
41,449
-184,291
-82% -$15.4M 0.02% 645
2017
Q4
$21.7M Sell
225,740
-18,204
-7% -$1.78M 0.12% 188
2017
Q3
$25.5M Hold
243,944
0.14% 170
2017
Q2
$23.9M Buy
243,944
+47,712
+24% +$4.7M 0.13% 174
2017
Q1
$20M Buy
196,232
+16,926
+9% +$1.74M 0.11% 202
2016
Q4
$17.3M Buy
179,306
+18,936
+12% +$1.64M 0.1% 219
2016
Q3
$14M Buy
+160,370
New +$16.1M 0.09% 265

Other funds holding VEON

Aviva's VEON Position: Q2 2018 in Review

Aviva sold out of VEON (VEON) in Q2 2018, closing a stake of 41,449 shares — an estimated $2.74M sold.

Aviva first reported a position in VEON in Q3 2016 and held it in 7 quarters. The position peaked at $25.5M in Q3 2017. 92 funds tracked by Wall St. Rank hold VEON as of Q2 2018.

  • Aviva reported no remaining VEON position as of Q2 2018 after selling out during the quarter.
  • Aviva sold 41,449 VEON shares in Q2 2018, an estimated $2.74M.
  • Aviva first reported a position in VEON in Q3 2016 and held it in 7 quarters.
  • Aviva's VEON position peaked at $25.5M in Q3 2017.
  • 92 funds tracked by Wall St. Rank held VEON as of Q2 2018.

Based on Aviva's 13F filing for Q2 2018, filed 1 Aug 2018.